Cite
HARVARD Citation
Moia, R. et al. (2020). Anti‐rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity. Hematological oncology. 38 (2), pp. 204-206. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moia, R. et al. (2020). Anti‐rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity. Hematological oncology. 38 (2), pp. 204-206. [Online].